Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,137.90
(
1.05%
)
US TECH 100
26,218.00
(
1.73%
)
Dow Jones
49,490.03
(
0.09%
)
Brent Oil
97.57
(
0.87%
)
Bitcoin
78,157.45
(
-0.10%
)
News Focus
News Focus
Post# of 257438
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Mufaso

Send PM Follow Ignore
Followers 42
Posts 697
Boards Moderated 0
Alias Born 01/08/2008

Mufaso

Re: Mufaso post# 251096

Tuesday, 04/23/2024 7:20:08 AM

Tuesday, April 23, 2024 7:20:08 AM

Post# of 257438
VKTX- VK2809 in NASH should read out ph2a 52 week biopsy (Fibrosis and NASH Resolution) data very soon. I'm modifying my best guess of when to be tomorrow Wednesday April 24th after the close to coincide with the VKTX earnings release.

Previously Viking readout 12 week top line data that was considerably better than MDGL rezdiffra (resmetirom). I expect VK2809 data to again be better than rezdiffra.

"People are best convinced by reasons they discover themselves"

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Unleash the power of Level 2

Spot liquidity moves with access to US order books.

Sign Up